| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |